서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 18 of 18

Issue DateTitle / Author(s) / CitationFileAltmetrics
1995-07
In vitro generation of immune effector cells from tumor-associated lymphocytes of human gastric cancer

KIM, HJ; HEO, DS; SUH, CI; KIM, HT; BANG, YJ; KIM, NK

Anticancer Research, Vol.15 No.4, pp.1247-1255

1998-05
Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-β1 expression

Yoon, SJ; Heo, DS; Kang, SH; Lee, KH; Kim, WS; Kim, GP; Lee, JA; Lee, KS; Bang, YJ; Kim, NK

Anticancer Research, Vol.18 No.3A, pp.1591-1596

1999-05
Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients

Kim, CW; Choi, SH; Chung, EJ; Lee, MJ; Byun, EK; Ryu, MH; Bang, YJ

Pathobiology, Vol.67 No.3, pp.123-128

DOI
2001-04
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study
DOI
2004-06
Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

Lee, June-Chul; Lee, Kyung-Mi; Kim, Dong-Wan; Heo, Dae Seog

Journal of Immunology, Vol.172 No.12, pp.7335-7340

DOI
2008-04
The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury
DOI
2012-02
Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer
view fileDOI
2015-10
High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy
DOI
2016-06
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
DOI
2016-06
Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas
DOI
2016-11
Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in mice

Pyo, Kyoung-Ho; Lee, You-Won; Lim, Sun Min; Shin, Eun-Hee

Oncotarget, Vol.7 No.45, pp.74107-74119

view fileDOI
2019-05
Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
DOI
2020-07
Comprehensive Molecular Profiles of Functionally Effective MSC-Derived Extracellular Vesicles in Immunomodulation
DOI
2021-04
Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody
DOI
2022-04
The Link module of human TSG-6 (Link_TSG6) promotes wound healing, suppresses inflammation and improves glandular function in mouse models of Dry Eye Disease
DOI
2022-07
Different levels of humoral and cellular immunity to varicella-zoster virus in seropositive healthcare workers
DOI
2022-08
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
DOI
2022-09
MHC Class I Enables MSCs to Evade NK-Cell-Mediated Cytotoxicity and Exert Immunosuppressive Activity
DOI
1